These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 31738617)
1. Recent developments in pharmacotherapy for hypertriglyceridemia: what's the current state of the art? Florentin M; Kostapanos MS; Anagnostis P; Liamis G Expert Opin Pharmacother; 2020 Jan; 21(1):107-120. PubMed ID: 31738617 [No Abstract] [Full Text] [Related]
2. Long-chain omega-3 fatty acids, fibrates and niacin as therapeutic options in the treatment of hypertriglyceridemia: a review of the literature. Ito MK Atherosclerosis; 2015 Oct; 242(2):647-56. PubMed ID: 26296750 [TBL] [Abstract][Full Text] [Related]
4. Investigational drugs in development for hypertriglyceridemia: a coming-of-age story. Rhainds D; Brodeur MR; Tardif JC Expert Opin Investig Drugs; 2019 Dec; 28(12):1059-1079. PubMed ID: 31752565 [No Abstract] [Full Text] [Related]
5. Targeting apoC-III and ANGPTL3 in the treatment of hypertriglyceridemia. Nurmohamed NS; Dallinga-Thie GM; Stroes ESG Expert Rev Cardiovasc Ther; 2020 Jun; 18(6):355-361. PubMed ID: 32511037 [TBL] [Abstract][Full Text] [Related]
6. Treatment of Hypertriglyceridemia: A Review of Therapies in the Pipeline. Xu J; Ashjian E J Pharm Pract; 2023 Jun; 36(3):650-661. PubMed ID: 34720008 [TBL] [Abstract][Full Text] [Related]
7. Cardiovascular Disease Risk Reduction in Mild-Moderate Hypertriglyceridemia: Integrating Prescription of Omega-3 with Standard Treatment. Picard F; Steg PG Curr Atheroscler Rep; 2021 Mar; 23(6):27. PubMed ID: 33788024 [TBL] [Abstract][Full Text] [Related]
9. The effect of omega-3 carboxylic acids on apolipoprotein CIII-containing lipoproteins in severe hypertriglyceridemia. Morton AM; Furtado JD; Lee J; Amerine W; Davidson MH; Sacks FM J Clin Lipidol; 2016; 10(6):1442-1451.e4. PubMed ID: 27919362 [TBL] [Abstract][Full Text] [Related]
10. Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: the EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial. Kastelein JJ; Maki KC; Susekov A; Ezhov M; Nordestgaard BG; Machielse BN; Kling D; Davidson MH J Clin Lipidol; 2014; 8(1):94-106. PubMed ID: 24528690 [TBL] [Abstract][Full Text] [Related]
11. Rationale for prescription omega-3-acid ethyl ester therapy for hypertriglyceridemia: a primer for clinicians. Bays H Drugs Today (Barc); 2008 Mar; 44(3):205-46. PubMed ID: 18536782 [TBL] [Abstract][Full Text] [Related]
12. Icosapent ethyl: a review of its use in severe hypertriglyceridemia. Kim ES; McCormack PL Am J Cardiovasc Drugs; 2014 Dec; 14(6):471-8. PubMed ID: 25428605 [TBL] [Abstract][Full Text] [Related]
13. Hypertriglyceridemia and cardiovascular risk reduction. Jacobson TA; Miller M; Schaefer EJ Clin Ther; 2007 May; 29(5):763-777. PubMed ID: 17697898 [TBL] [Abstract][Full Text] [Related]
14. Omega-3 carboxylic acids in patients with severe hypertriglyceridemia: EVOLVE II, a randomized, placebo-controlled trial. Stroes ESG; Susekov AV; de Bruin TWA; Kvarnström M; Yang H; Davidson MH J Clin Lipidol; 2018; 12(2):321-330. PubMed ID: 29289538 [TBL] [Abstract][Full Text] [Related]
15. Recent advances in treating hypertriglyceridemia in patients at high risk of cardiovascular disease with apolipoprotein C-III inhibitors. Spagnuolo CM; Hegele RA Expert Opin Pharmacother; 2023 Jun; 24(9):1013-1020. PubMed ID: 37114828 [TBL] [Abstract][Full Text] [Related]
16. Triglyceride-Rich Lipoproteins and Novel Targets for Anti-atherosclerotic Therapy. Reiner Ž Korean Circ J; 2018 Dec; 48(12):1097-1119. PubMed ID: 30403015 [TBL] [Abstract][Full Text] [Related]
17. A Review of Clinical Practice Guidelines for the Management of Hypertriglyceridemia: A Focus on High Dose Omega-3 Fatty Acids. Karalis DG Adv Ther; 2017 Feb; 34(2):300-323. PubMed ID: 27981496 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological treatment options for severe hypertriglyceridemia and familial chylomicronemia syndrome. Chaudhry R; Viljoen A; Wierzbicki AS Expert Rev Clin Pharmacol; 2018 Jun; 11(6):589-598. PubMed ID: 29842811 [TBL] [Abstract][Full Text] [Related]